Next Science Ltd (AU:NXS) recently announced a significant update regarding its sales force restructuring. The company made changes to its sales team in order to reduce costs and improve efficiency, with the goal of saving approximately US$6 million annually.
Despite the restructuring, Next Science Ltd has reported an increase in product sales and a strong gross margin. As a result, the company is confident in meeting its FY24 revenue guidance of US$36m-$40m. Additionally, Next Science Ltd anticipates achieving EBITDA and cashflow positivity in the second half of the fiscal year.
The strategic shift in the sales force includes transitioning to a flexible, commission-based structure. This change is part of Next Science Ltd’s efforts to capitalize on new market opportunities and drive future growth. Investors interested in learning more about AU:NXS stock can visit TipRanks’ Stock Analysis page for additional insights.
